Washington, DC 20006-5349
HELPLINE
Dr. Patrick Forde, director of the Thoracic Cancer Clinical Research Program and associate professor of oncology at Johns Hopkins Medicine, gives an update on how…
Mary Hesdorffer, NP, executive director of the Mesothelioma Applied Research Foundation, interviewed Boris Sepesi, MD, a thoracic surgeon at MD Anderson Cancer Center. The conversation…
Members of the mesothelioma treatment team at the University of Maryland Medical Center — Joseph Friedberg, MD; Melissa Culligan, RN, MS; and Erica Glass, NP…
Steve W. is a 56-year-old husband and father of three who was diagnosed with pleural mesothelioma in June 2018. Following his diagnosis, Steve and his…
Bristol Myers Squibb announced today that CheckMate -743, a pivotal phase 3 trial evaluating Opdivo (nivolumab) in combination with Yervoy (ipilimumab) in previously untreated malignant pleural mesothelioma, met its primary endpoint of overall…
Steve W. is a 56-year-old husband and father of three who was diagnosed with pleural mesothelioma in June 2018. Following his diagnosis, Steve and his…
Steve W. is a 58-year-old husband and father of three who was diagnosed with pleural mesothelioma in June 2018. Following his diagnosis, Steve and his…
Mary Hesdorffer, NP, executive director of the Mesothelioma Applied Research Foundation, interviewed mesothelioma expert Dr. Daniel Sterman, NYU, to discuss the current situation in New…
In light of the current outbreak of the novel coronavirus disease, (known as COVID-19), we have consulted with medical experts on our Board of Directors…
In light of current developments with regard to COVID-19, the International Symposium on Malignant Mesothelioma previously scheduled for April 6 and 7 in San Antonio, Texas, will be rescheduled. This decision comes after careful deliberation and…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
